
- 积分
- 3
- 威望
- 3
- 包包
- 20
|
2,3-DPG:2,3-diphosphatidylglyceric acid,2,3-二磷酸甘油酸7 R) D e8 C' k; A4 V: `! ^
2-CdA:2-chlorodeoxyadenosin,cladribine,2-氯去氧腺苷3 Q5 E$ n( G9 h( R& S; _' G" `) F
3H-TdR:tritiated thymide,氚标记胸腺嘧啶核苷& z9 `* U+ J6 e% F" }/ N
5-Aza:5-azacytidine,5-氮(杂)胞苷
6 C, C& Q3 G. R. e7 _1 ?a2-PI:a2-antiplasmin, a2-纤溶酶原抑制物( X5 n& w3 a4 O: B4 B- c
AA:aplastic anemia,再生障碍性贫血/ v7 t$ Q; V; t/ P- {9 T' b8 O
AAV:adeno-associated virus,腺病毒相关病毒" |( U7 j$ {) o5 M/ h$ X, {
Ab:antibody,抗体
2 x! S a5 w0 N5 ]* D9 NABC:avidin-biiotin complex method, 亲和素生物素复合物法& K |: j& q. ^/ p- R* [2 n
ABMT:autologous bone marrow transplant,自体骨髓移植# N& O1 ?- h1 ^" m- y' Q
Ac:accessory cell,辅佐细胞; A7 u+ n8 N: w
ACD:acid citrate dextrose,酸性枸橼酸盐葡萄糖- Y, C/ s; H& _8 Y- N- ~: T
ACP:acid phosphatase,酸性磷酸梅
- l% d' {+ o$ s, {& P; U* {ACTD:actinomycin D,放线菌素D
, U* ^* c/ A* }* XAcute:急性的 u, \5 Q0 d3 Q2 X4 i: s! X
ACV:cyclovir,阿昔洛韦/ z- g4 s* Z, T
Ad:adenovirus,腺病毒, u9 v0 W7 E& Q7 W8 h5 ?
AD:antigen determinant,抗原决定簇/ L3 J3 Z: U4 P4 x
ADA:adenosine deaminase,腺苷脱氨酶' \; c+ c8 R* Z" N: e% _
ADCC:antibody-dependent cell-mediated cytotoxicity)抗体依赖细胞介导性细胞毒性% A+ p( q3 S* ] ]2 B
Adjuvant therapy:辅助治疗; s" \* ^' p$ @! k" u9 \$ Y: d' S
AEL:acute erythrocytic leukemia,急性红白血病
: F5 q: Y2 Z6 L. P2 a5 k* KAEoL:acute eosinophilic leukemia,急性嗜酸粒细胞白血病' R9 i# Q. ?4 o" [( I
AFP:alpha fetoprotein,甲胎蛋白; q1 d. ]- D1 T/ c3 {2 [
Ag:antigen,抗原' P' Z- T7 X r4 ~- ~
aGVHD:acute graft versus host disease,急性移植物抗宿主病
7 ]- c S% |3 W J, v v: @Aid:anti-idiotype antibody,抗独特型抗体
& V) J8 _7 \ e! j$ ?* [" G# P; tAidS:acquired immune deficiency syndrome,获得性免疫缺陷综合征" D8 m7 B. U& p4 d, A
AIF:apoptosis-inducing factor,凋亡诱导因子+ c8 _2 F d. J5 Q( n# h- C
AIHA:autoimmune hemolytic anemia,自身免疫性溶血性贫血
7 T) u% u; r9 q( R5 e1 J( tAL:acute leukemia, 急性白血病6 X5 H# X6 s# R' `' O7 L
ALCL:anaplastic large cell lymphoma,退行性大细胞淋巴瘤
1 I% l! @( [& `8 P0 J' t1 iALG:antilymphocyte globulin, 抗淋巴细胞球蛋白4 {, y% m2 ?2 y Z. d% q
ALIP:abnormal localization of immature precursor,未成熟前体细胞异常定位9 E) s0 n# O* n5 N& H4 [4 Q
ALL:acute lymphocytic leukemia,急性淋巴细胞白血病# F$ R. s- t" m! u, g' F8 C( U
Allo-BMT:allogeneic bone marrow transplantation,异基因骨髓移植6 s; X6 k1 y+ L# w- {) z0 g# p
Allo-PBSCT:allogeneic peripheral blood stem cell transplantation,异基因外周血干细胞移植% @- ?9 F# e) J7 G
Allogeneic:异基因的
* b: X- Z# s2 `9 N7 AAllograft:异体移植物
: \/ g1 X4 H. V* k9 _2 A. E* |Alopecia:脱发+ W {$ O- ~. A8 Z9 c* |7 ]! Z' f0 q
ALP(AKP):Alkaline phosphatase,碱性磷酸酶: x \. |) K! C3 E3 i
AM:adhesion molecule,粘附分子/ X0 b9 ~2 _ p& s: e7 K
AMKL:acute megakaryoblastic leukemia,急性巨核细胞白血病
# q+ n0 z+ F d" `- b% I7 M0 {6 y6 eAML:acute myeloid leukemia,急性髓性白血病9 N8 T( J2 ~4 M8 E. Y9 s
AMM:agnogenic myeloid metaplasia,特发性髓外化生
- U( ?; v3 I) l" W4 TANA:antinuclear antibody,抗核抗体
# l5 @4 e5 w/ l2 H* u" U4 lAna-LL:anaplastic large cell lymphoma,大细胞淋巴瘤
1 l* V* o) x" K- E2 c7 l6 M) `Anaphylaxis:过敏症3 m- V+ H" j/ Q. z( U; E
6 W' W( ` [0 f4 ~) E% q
ANC:absolute neutrophil count,中性粒细胞绝对值
2 }( R+ U" Z, T( B! ^3 e1 [! dAnemia:贫血+ O4 ?# z2 W- i3 U4 q1 [9 C" t# S
ANLL:acute non-lymphocytic leukemia,急性非淋巴细胞性白血病 E! K/ S# C( c
Antibiotic:抗生素;抗生的 ) X8 x! a% a5 k$ d- u; n1 ^' a
Antiemetic:止吐剂,止吐药 9 O6 J! A6 m! M W y8 {
antineoplastic drugs:抗肿瘤药物
) `; F- S* B2 r- c# a8 D8 ~( vAntisense:反义引物( H: Q1 j1 K z9 g# L$ O" s
APBSCT:autologous peripheral blood stem cell transplantation,自体外周血干细胞移植
9 |5 m+ e, \! W6 b7 @: H5 @APC:antigen processing cell,抗原呈递细胞9 C5 O% Q: ^( U9 c4 u' J" r; j
Apheresis:血浆分离置换法,血液成分部分清除 0 r1 v; ~) I. m7 x" K
APL:acute promyelocytic leukemia,急性早幼粒细胞白血病1 k* |+ z8 `0 ` x& a
Aplasia:发育不良,成形不完全
1 p' g( ?0 d3 Y# mApoptosis:凋亡: |5 z$ ^! w" _
Ara-C:arabinosyl cytosine,aracytidine阿糖胞苷
( K# Q1 u8 F: h0 G7 BARDS:acute respiratory distress syndrome,急性呼吸窘迫综合症;AidS-related diseases艾滋病相关疾病
3 r( m0 H+ z! @! p" F6 ^% XAscites:腹水
1 n$ }; ?5 Y5 BASCT:autologous stem cell transplantation,自体干细胞移植* ]' a) f: N! w* G5 ]9 q- e
Aspergillus:曲霉属
; U4 f! t6 T' |: w4 f) }1 T6 UASS:anterior superior spine,髂前上棘; N. c' G) |/ e4 C6 O6 |0 t& N
AT1257:nitrocaphane,消瘤芥: b( y( T% |/ a, U# A: p w+ z2 Z
ATG:antithymocyte globulin,抗胸腺细胞球蛋白7 g8 y* V' Q; n M
ATL:adult T cell leukemia/lymphoma,成人T细胞白血病/淋巴瘤, N6 m5 d) S8 t, L5 k
ATLS:acute tumor lysis syndrome,急性肿瘤溶解综合征
! Y) ?- V6 G# gATRA:all-transretinoic acid,全反式维甲酸
& x/ f; D/ J( d8 \. }AUL:acute undifferentiated cell leukemia,急性未分化细胞白血病
5 m; ?: W) S$ G5 A! rAuSCT: autologous stem cell transplantation,自体造血干细胞移植
6 e$ l! p% a9 U" p- O% n! k! F& pAutologous:自体的
( W7 @( X- `; a0 d4 JAutograft:自体移植物
, ?; L) s3 V% k- {- R8 fAuto-BMT: autologous bone marrow transplantation,自体骨髓移植2 o# P. T# Q7 a$ [1 K+ I
β2-MG:β2-microglobulin,β2-微球蛋白
$ c# ~ @# Q* n4 O, t9 SBack-up:备份
% A- X X- k# }( f: ^: MBCNU:Carmustine,卡氮芥,卡莫司汀
; d2 B1 x. U% ?BCR:breakpoint cluster region,断裂点丛集区' g1 O' T6 Z3 |- V/ _
BFU-E: burst-forming unit-erythroid,早期红系集落生成细胞* s* |6 Q1 y7 a/ m- w
Biopsy:活检 : Z/ W J7 `% \& h7 n- s4 L
Blast cell:原始血细胞,母细胞 2 w& q$ r% Q9 b7 n
Blast-CFC:blast colony forming cell,原始细胞集落形成细胞7 D9 |# V' V+ |# i3 z$ s
Blast crisis:原始细胞危象
4 a) l! x, c" H6 UBm:memory B lymphocyte,记忆B淋巴细胞1 {* ^8 H% e7 k2 e1 f3 H0 a
BMG:benign monoclonal gammopathies,良性单克隆丙球蛋白病; a9 R- g- ]' |; C8 C' P1 E6 I3 k
BMT:bone marrow transplantation,骨髓移植
% c( _0 Z2 p7 ^; I1 @$ Y, Q5 GBone marrow biopsy:骨髓活检
( F* ~0 o5 A' G& Q: D3 c7 YBone marrow puncture:骨髓穿刺8 U% \- _) I% |. u8 M
Bone marrow smear:骨髓穿刺涂片
, D+ h+ H+ f! ^4 [4 HBRM:biological response modifier,生物应答调节剂- Q( f. ]. z$ H
Bu:busulfan,白消安,马利兰
# |0 w X) _. C/ Q7 YBuffer:缓冲,缓冲剂,缓冲液
$ T1 `& F& D# i4 B+ dCALLA:common acute lymphocytic leukemia antigen,普通急性淋巴细胞白血病抗原
% l) k4 _0 i" Y% D. F% oCAM:cell adhesion molecule,细胞粘附分子* c2 J& o7 \. V
Candida:念珠菌属,假丝酵母属 9 G5 O4 l1 h' C# S
Catheter:导管
3 D# S k. U1 F" U& CCB:cord blood,脐带血
, \8 B" O9 z. h2 r( Z0 [CB1348:chlorambucil:苯丁酸氮芥% t6 V" h, i/ i4 W! h4 g! I) M
CBC:complete blood count,全血细胞计数 % ~) C( p( S9 i: Z" R9 |
CBCL:cutaneous B-cell lymphoma,皮肤B细胞淋巴瘤
2 a; t" m+ L, v7 Q" qCBSCT:cord blood stem cell transplantation,脐血干细胞移植
. E4 }; y: g) b* X6 CCCI:corrected count increment,校正增值计数
; k/ m9 R `2 p/ x' Z4 E TCCNSA:cell cycle non-specific agents,细胞周期非特异性药物
9 L% y4 J2 O: RCCNU:lomustine,洛莫司汀,环己亚硝脲
. C3 S- G X% ]; U( }, l- r5 zCCR:continuous complete remission,持续完全缓解
( q1 }8 ?2 } `8 i cCCSA:cell cycle specific agents,细胞周期特异性药物7 p! m% B+ S4 g3 O
CD:Castleman's disease,Castleman病
n( K' Z; z6 Z0 ]+ _/ `CD:cluster of differentiation,分化群* G. v& W% n5 P* q; d7 z$ p5 T1 m
CD3AK:CD3 activated killer,CD3激活的杀伤细胞$ g( y; K1 J9 N. g
CDK:cyclin dependent protein kinase,周期素依赖蛋白激酶
+ ]# I& Q$ z; y( _$ J' H: zCEA:carcinoembryonic antigen,癌胚抗原
8 i {" L {% B) g" ZCEL:chronic eosinophil leukemia,慢性嗜酸性粒细胞白血病
4 B4 x2 V8 s# x9 @. e/ _' b, BCentral line:中心静脉导管,见central venous catheter. ( w% H% D1 _8 ^; j u. J8 B; b
Central venous catheter: 中心静脉导管,又叫做central line,Hickman catheter 4 Z8 E5 C- z) z; ?. k' B+ k% x
Centrifugation:离心: j. H2 B c$ `
CFC:colony-forming cell,克隆形成细胞: ?# w% l. F/ x
CFU:colony-forming unit,集落形成单位
; J! J9 L- j3 Y7 vCFU-Blast:colony-forming unit-Blast,原始集落生成细胞
0 A, l8 I O% c0 [CFU-E:colony-forming unit-erythroid,红系集落生成细胞
; h$ }4 K* M& \. W4 z( D0 TCFU-G:colony-forming unit-granulocyte,粒系集落生成细胞: N, F+ t& h, z" g4 t' b' ]1 p# W
CFU-GM:colony-forming unit-granulocyte/macrophage,粒单系集落生成细胞
! ^! N5 S9 R4 K8 v4 kCFU-L:colony-forming unit-leukemia,白血病细胞集落生成单位3 O( t4 v& \, c" W _% P4 @
CFU-MEG:colony-forming unit-megakaryocyte巨核系集落生成细胞
, e3 [1 k9 x5 eCGD:chronic granulomatous disease,慢性肉芽肿病, Q% K2 R, U* _5 u# c
CGP:circulating granulocyte pool,循环粒细胞池) X" m+ V2 ~+ B' C7 @- T) I- u
cGVHD:chronic graft versus host disease,慢性移植物抗宿主病# K& z v( l) }. g
Chemo-responsive:化疗敏感的 4 \. C- m2 I& \7 W' p7 u3 k
Chemotherapy:化学疗法 5 S( K5 m9 b8 M; \
Chronic慢性的
7 b+ `/ `! g7 a/ J: d4 E2 L. Q2 l2 yC.I.:continuous infusion,持续静脉点滴% H; a/ @+ X" }: K z
CIK:cytokine-induced killer cells 细胞因子诱导的杀伤细胞! L7 \1 s! Y4 X
CliniMACS:clinical magnetic activated cell sorting,临床级磁性活化细胞分选系统
6 D3 Y# f+ ^" A2 ?6 P2 {CLL:chronic lymphocytic leukemia,慢性淋巴细胞白血病7 [8 ~# z1 W1 F; H
CML:chronic myelogenous leukemia,慢性粒细胞白血病
1 Y% ^2 t1 v4 {( z: o' QCML-AP:CML-accelerated phase,慢性粒细胞白血病加速期
) L1 m5 b; v) Q5 A1 QCML-BP:CML-blastic phase,慢性粒细胞白血病急变期
5 o: F% h) S7 JCML-CP:CML-chronic phase,慢性粒细胞白血病慢性期2 c/ q1 w# b! X/ k' k9 k
CMML:chronic myelo-monocytic leukemia,慢性粒-单细胞白血病' q3 F( j% ^! C: L2 O0 `
CMPD:chronic myeloproliferative disease,慢性骨髓增生性疾病
9 o$ I( _& r. P1 \CMV:cytomegalovirus,巨细胞病毒
( X6 Q+ |% b8 @: C2 y: ] ZCNR:cytokine negative response cell,细胞因子不反应细胞
8 r2 H1 m2 K5 J0 \. H1 F# j$ \CNS:central nervous system,中枢神经系统
* N8 u! T2 C! HCNSL:central nervous system leukemia,中枢神经系统白血病
+ d- g6 q$ ^9 x1 JCollection: 采集$ z0 M9 z( ~! w. d9 ?# H# p
Colony stimulating factor:集落刺激因子 ) j! x+ ~4 U1 T- x' a+ i
c-onc:cellular oncogene,细胞癌基因
: J; k9 x4 P7 n7 Y jConditioning:预处理
7 p+ {0 `& H) ]7 M' J4 f) EConjunctivitis:结膜炎# {7 @+ b6 o1 V3 w. |
Convalescence:恢复,恢复期
+ _- W: y O( R- TCP:cancer procoagulant,癌性促凝物质$ ?: y6 t/ h8 C" z) F
CPD:citrate phosphate dextrose,枸橼酸盐-磷酸盐-葡萄糖
9 w4 j* u( a# S. rCPDA: citrate phosphate dextrose adenine,枸橼酸盐-磷酸盐-葡萄糖-腺嘌呤
( C* Y* N/ X* v& ~0 ]. h) oCpmax:peak concentration,峰浓度3 l5 ?& _3 j/ P2 c% E! K
CPT:camptothecine,喜树碱7 S& \- S1 M* ?; ^4 A0 F' Q* W% d
CR:complete remission,完全缓解
9 E9 ^. R! B* ]8 t* TCRABP:cytoplasmic retinoic acid binding protein,胞浆维甲酸结合蛋白
6 A& `$ } ? G0 X$ W) UCRP:C reaction protein,丙反应蛋白
$ K. `! I _4 R1 E' {CRR:complete remission rate,完全缓解率 B8 o4 L7 v& m' Y
Cryopreservation:冷冻保存,深低温保藏
! A% l$ Z2 e) }0 JCSF:colony stimulating factor,集落刺激因子1 H. b$ s0 G, [
CSF:cerebrospinal fluid,脑脊液
0 V t4 s6 ?# Y8 C4 o$ z# k, x, ECTCL:cutaneous T cell lymphoma,皮肤T细胞淋巴瘤
) ~' B# D, v; m$ OCTCL:central T cell lymphoma,中枢T细胞淋巴瘤* J( r- F' i6 |! J% Z8 ?
CTL:cytotoxicity T lymphocyte,细胞毒性T淋巴细胞
" M' w! {5 w5 @ _' I: TCyclin:周期素
8 M) v/ Z G) n9 V! S6 I7 ICytomegalovirus:巨细胞病毒
- z3 M2 M A0 p: _7 jDC:dendric cell,树突细胞
* h3 o9 ^9 L- [D-D:D dimer,D-二聚体
- y$ r8 n+ w' L# f/ L- oDel:deletion,缺失* _& z9 U# a- G: N0 q f( E
Dermatitis:皮炎
% e. r: ?( a1 p% E# \# oDe nova AML:非继发性急性髓性白血病
# ]2 |1 U6 H" E0 B" \2 I5 m# u1 @DFS:disease free survival,无病生存期
( F7 d) l4 [( u) R4 M( }DI:DNA index,DNA 指数
# W8 q( P- R, RDIC:disseminated intravascular coagulation,播散性血管内凝血' b! {6 Y" C. w$ p
Dilution:稀释% o. z, o* i( K5 x0 V
DL:discordant lymphoma,混杂型淋巴瘤
# V5 a2 ]; _" ~( G$ }7 TDonor:供者
2 B( X9 C8 F/ Z3 d! K& qDysplasia:发育不良,发育异常 5 S+ D8 S! V3 e) u6 F# I
EBV:Epstein-Barr virus,EB病毒
) y d( e) A" A# VECM:extracellular matrix,细胞外基质
9 `. s4 p; I$ m. p+ A-ectomy:(后缀)(外科)切除,除去,去掉 1 [5 c- o$ f: g+ @. C7 ^$ x; N
Edema:水肿
( L$ a0 _8 C- d: Y4 AEGF:epithelial growth factor,表皮生长因子
! p0 H5 p1 J; Y: ]2 I-emia:(后缀)血液疾病
@/ D0 Y- ^5 u! VEncephalopathy:脑病
+ N: P; Z+ O' Q9 P8 g, K( Z( {' qEncode: 编码
6 c* k% D2 h2 J0 q( S- vEngraftment:移植物植入
5 Q! p9 N! Y+ J5 D; G2 B: \Enrich:富集
6 K Q/ I# D' @# Z7 R) WEnzyme:酶 5 ~ m+ w( _- [. k% y
Eosinophil:嗜酸性粒细胞
, Z0 ~; D: a9 H v1 }7 _% X4 H M( KEPO:erythropoietin,促红素,红细胞生成素/ [: k3 f( Q7 `! o- \: G. p
ETT:essential thrombocythemia,原发性血小板增多症+ z. B: G4 _; W" G) F B
Ex vivo:体外
$ E- s8 |) N! H4 p( |' F9 OFACS:fluorescence activated cell sorting,荧光活化细胞分选系统7 y" p7 ~5 J6 }* B
FCM:flow cytometry,流式细胞分析技术
# Z p1 I7 j1 V8 j h, L4 N0 ZFDC:follicular dendritic cells,滤泡树突状细胞
: @5 n7 i2 P$ gFDGF:fibroblast derived growth factor,成纤维细胞源生长因子
4 ^/ l( M9 q- f. m/ I8 ?Febrile:发热的 i* j1 T3 e' m7 k; w
FFP:fresh frozen plasma,新鲜冰冻血浆3 C x Y4 C6 x |/ R
FGF:fibroblast growth factor,成纤维细胞生长因子
( D4 _- w% S2 x) Q5 sFHH:familial hemophagocytic histiocytosis,家族性嗜血组织细胞增生症
1 F2 i' @, B7 t5 G: s8 c& VFISH:fluorescence in situ hybridization,荧光原位杂交7 ^; ?$ N. ?" q# e6 F
FMF:familial Mediteranean fever,家族性地中海热
d8 d2 I/ D" XFoley catheter:弗利氏导尿管,气囊导尿管 & l% K9 g9 T4 v9 h0 m, }5 G
FrTBI:fractional total body irradiation,分次全身照射
0 ]4 d @6 K3 ]6 kFSRC: 胎羊体内增殖的人造血干细胞! T# P' K$ w3 w( l$ C, r: H9 ?
Fungus:真菌 , l- d6 w% J- e* W) J' H0 w0 X) p
Fungi: Fungus复数形式
" ?& N9 c* \ T- z% K* lG6PD:glucise-6-phosphate dehydrogenase,6-磷酸葡萄糖脱氢酶
2 X. `( J$ G; b" a5 HGastritis:胃炎
6 K" q0 O0 s2 b, `5 L; d! }Gastrointestinal:胃肠道的 ( b2 v) d3 c8 R S& O
G-CFC:granulocyte colony forming cells,粒细胞集落形成细胞
. r0 m3 i6 j# j: t1 \# IG-CSF:granulocyte colony stimulating factor,粒细胞集落刺激因子
/ \0 j* L% g/ d1 }2 d* Y$ e, kGCV:cytomegalovirus,巨细胞病毒6 u* n$ z4 R0 t% w6 l0 O z
GCV:ganciclovir,更昔洛韦; ?; ?/ A8 |! B- E4 g5 W
GI:gastrointestinal,胃肠道的
2 x D* D2 M$ }2 j0 iGM-CSF:granulocyte-macrophage colony stimulating factor,粒-巨噬细胞集落刺激因子 * p: x8 ]' r6 E8 f& X9 m- |) j
GM-CFC:granulocyte-macrophage colony forming cells,粒-巨噬细胞集落形成细胞
+ I$ A2 H- R3 \, ^) t6 cGraft rejection:移植排斥(反应)
' j J! P, h4 R4 ~Graft-versus-host disease:移植物抗宿主病
! r/ [: I1 x' {Granulocyte:粒细胞
2 \/ J/ A- y: i/ P- KGrowth factor:生长因子 ) @( w K. L) A/ |3 ^! |
GTR:granulocyte turnover rate,粒细胞转换率
; F y4 O, y$ v# p! C4 U+ ~GVHD:graft-versus-host disease,移植物抗宿主病 3 ?. A, P/ r' W- X1 R
GVHR: graft-versus-host reaction,移植物抗宿主反应7 L: P$ t" N# [/ f$ B
GVL:graft-versus-leukemia,移植物抗白血病
& `5 k# |) l" j: H- AGVT:graft-versus-tumor,移植物抗肿瘤7 q ?3 Z9 {# a; { |5 U$ `
Haploidentical: 半相和的
& O4 O6 N1 Y9 {5 T) @4 n; pHarvest: 收集,采集) w3 q; B) _5 {% m8 H% H7 |
HC:hemorrhagic cystitis,出血性膀胱炎, x! j M: |: ]$ E4 o
HCL:hairy cell leukemia,毛细胞白血病
1 m! e4 j! s3 Z; t+ v8 \HD:Hodgkin's disease,霍奇金病
: J# R8 B& G* a; T0 r5 KHD:high dose,大剂量
! G$ c# A7 p; Z; m0 M- L% }; A3 e+ tHematocrit:红细胞压积 " L/ k r5 h7 k; ?* v' ^8 z1 l( U$ O
Hematology:血液学 * W4 \' k' Y" @
Hematopoiesis:造血作用,生血作用. z9 ^6 i6 w+ L d
Hematopoietic system:造血系统
8 ^5 H H# l" c& D5 d# @Hemoglobin:血色素,血红蛋白
; n4 o. M8 l8 q) E2 {Hemorrhage:出血 ! L) r4 J' }" U, V, p4 Y8 D
Hemorrhagic cystitis:出血性膀胱炎
" s4 b( o2 l4 P6 f* U3 bHepat - :(前缀)肝的
, k. A. f$ Q! I; N( y6 z0 E2 i; CHepatitis:肝炎
" T \& T/ Y, R n0 D. ?0 BHES:hypereosinophilic syndrome,高嗜酸粒细胞综合征
7 _3 N' ^1 f1 |/ ? P1 u; S2 |5 A% QHGF:hematopoietic growth factor,造血生长因子, t4 ~1 d$ o C0 p8 t }
HHV:human herpus virus,人疱疹病毒) y- ]9 N( _3 P. u# C' m' [
Hickman catheter:Hichman导管,中心静脉插管 # T* I/ U1 V: {$ K2 L* N( U" n
HIV:human immune deficiency virus,人免疫缺陷病毒
+ X% Z( [. \6 r: h& L+ qHLA:human leukocyte antigen,人类白细胞抗原 9 H$ J: @4 e2 Y7 n! }- K5 x0 g) h
HLH:hemophagocytic lymphohistiocytosis,嗜血细胞性淋巴组织细胞增生症
8 k8 E1 \ N9 Z1 p( uHMR:histiocytic medullary reticulosis,组织细胞性髓性网状细胞增生症
% ]7 T _7 p) k' U0 dHomogenic transplantation:同基因移植
) B& O/ Z4 c% o# c+ THomozygote:纯合子
/ R# R- Y/ s" z3 w4 T" g. jHPC:hematopoietic progenitor cell,造血祖细胞
. @3 L5 R% A' x) E0 jHPP-CFU:high proliferative potential colony-forming unit,高增殖潜能集落形成单位$ U7 v8 N# g5 F$ t
HR-ALL:high risk ALL,高危型急性淋巴细胞白血病" i* ~1 `1 T5 Q+ a
HSC:Hand-Schuller-Christian disease,韩-薛-柯病2 [0 e) `2 m2 C) I
HSC:hematopoietic stem cell,造血干细胞
' U( Z6 E ^6 L2 z( Z9 Q' v# EHSR:homogenously staining region,均染色区: S7 @; J9 l& l4 A( P
HSV:herpes simplex virus,单纯疱疹病毒
, u- y: O; I {0 ?# ?9 q2 KHTC: typing cell,纯合子分型细胞
Y( E2 ~1 }+ g4 a& ~$ u0 _) @, S; RHTLV:human T cell leukemia virus,人类T细胞白血病病毒
5 U% m3 u. R1 l* G' \, b) v: pHVOD:hepatic venous occlusive disease,肝静脉闭塞病
! Q4 w$ V* a; d8 O% J# xHyper- :(前缀)高,超,(过)多; r+ t1 c v" Z1 L& L
Hyperalimentation:高营养支持,静脉高营养
- I' q1 n; c0 _Hyperpigmentation:色素沉着过度
8 n: I; g7 n' Q! q9 Y" LHypertension:高血压 + m( A; C* v, {7 w; W
Hypo- :(前缀)(过)低,少于) z8 R* @0 y" k+ C
Hypotension:低血压# G8 ~& x/ v3 w) i
IAHS: infectous-associated hemophagocytic syndrome,感染相关嗜血细胞综合征
5 r8 }5 c% F0 M8 D. n' @id:medium dose,中剂量& Y# y: u. K2 S& T
id:initial dose,初始剂量/ [/ F; u [% Q1 K: r" P' g) ^
IF:involved field,累及野
. ^! ], r7 i( D1 lIFN:interferon,干扰素
3 y# q. {" ~$ M- IIg:immunoglobulin,免疫球蛋白
8 _3 }6 C g! t' o8 UIGFs: insulin-like growth factor,胰岛素样生长因子9 y) \( K& W7 C8 u
IgH:immunoglobulin heavy chain,免疫球蛋白重链/ }- |* d; F. o4 G, N
IL:interleukin,白细胞介素
& o7 z) n, T" W& i. nIliac crest:髂嵴 8 Y% k6 b4 A# |
I.M.:intramuscular,肌肉注射/ o' g) u+ C' _2 [5 l( r5 {
Immune system:免疫系统
( o- e/ F: G: e% | cImmunocompromised:免疫受损的 ' e# w1 |' F2 O8 C/ w: ~* U
Immunoglobulin:免疫球蛋白
~9 u' V, k0 `Immunological tolerance:免疫耐受( ?3 m$ h! n9 l. d3 O2 |; t
Immunosuppression:免疫抑制
9 _( S9 ]; O i- \Incubation:孵育
! M6 f6 B: z6 T* einformed-consent:知情同意* Q% K1 O- k4 |2 e
Intravenous:静脉内的
3 M4 D' m- y- o- x4 Z8 tinv: inversion,倒位
- S& _) ?+ \) O) R: A. Ein vitro: 体外,离体
7 d4 r/ b( }2 z( {& G; Xin vivo: 体内
/ v8 t. N' i% OIP:interstitial pneumonia,间质性肺炎
: D( J8 _# X# B# SIsolation: 分离
/ v0 o5 I3 @/ z8 c0 L6 bI.T.:intrathecal injection,鞘内注射9 F3 Y4 |* K" g% n
-itis:(后缀)炎症 - A. S" ~+ q/ s7 P8 r
ITP:idiopathic thrombocytopenia purpura,特发性血小板减少性紫癜2 z+ O1 i9 M, `
Jaundice:黄疸. W" P9 C. _( s
KPS:Karnofsky score, Karnofsky评分
$ H( w" B6 [2 R* W5 N" R$ ELAK:lymphokine-activated killer(cells),淋巴因子激活杀伤(细胞)) w0 K/ P4 ^7 V
Laminar air flow unit:层流间 : k0 Q& q) P: ~2 w
LCH:Langerhans cell histiocytosis,郎格罕细胞(组织细胞)增生症( s( U/ X) W$ S" r0 K
LD:lymphocyte depletion,淋巴细胞消减型; m7 t, P) v' W0 ~7 d
LD:low dose,小剂量4 l3 }1 F! Q& v( B" x) r. k5 h1 z3 v) b
LDH:lactate dehydrogenase,乳酸脱氢酶+ Z' C) ^" b$ o \- ~) J
Leukapheresis: 白细胞采集物% h; c" s1 H5 n+ F2 B9 v# f' J& o
Leukemia:白血病
; E+ c9 `. e' ^5 I9 m2 C+ U; vLeukocyte:白细胞
6 E! s& ^ P, W4 K( S/ bLeukopenia: 白细胞减少症
8 [' Z. m M2 {; }' u9 BLFA:lymphocyte function associated antigen,淋巴细胞功能相关抗原 1 S' Q* H% q9 [3 Q/ B
LFS:leukemia free survival,无白血病存活期; [% v8 y- J) M; F
LGL:low grade lymphoma,低度恶性淋巴瘤
0 ~% M0 L$ d! c5 {4 v0 b2 LLHR:lymphocytic homing function receptor, 淋巴细胞归家功能受体
) Z% Z% j, P/ n& A. F6 p+ rLI:labeling index,标记指数
$ Z' S4 H( M+ y: L% ^LIF:leukemia inhibition factor,白血病抑制因子9 ?! k' ~: N# |
Lineage:系7 {" f: u7 j2 H. W$ K+ [
LOH:loss of heterozygosity,杂合性丢失
7 C+ N- ], R, A6 o8 k- ^3 Y3 JLP:lymphocyte predominance,淋巴细胞为主型5 L- N* z+ N1 X- S/ G6 r4 e
LRP:lung resistance related protein,肺抗性相关蛋白
$ b# F6 y s8 W Q6 G: LLTB:life-threatening bleeding,致命性出血
+ l& D2 b: B p: V2 p O( nLTC-IC:long-term culture-initiating cell,长期培养起始细胞
: R; c/ A& }) g, H* RLTR:long terminal repeat:长末端重复序列/ R5 U; o# C' C w z! G
LVL:large volume leukapheresis,大容量白细胞单采 F0 r: ~) z1 x
Lymphocyte: 淋巴细胞5 D. f6 k6 K6 X# g7 |3 `0 ~
Macrophage:巨噬细胞
: K7 C0 H& @! a$ f2 ~( \' `MACS:magnetic activated cell sorting,磁性活化细胞分选
$ p! g, s' G% |9 {7 kMAK: monocytokine-activated killer(cells),单核细胞因子激活杀伤(细胞)
. J8 `0 P- k- R( oMalabsorption:吸收障碍) N; e& F0 i0 v9 ^
MALT:mucosa-associated lymphoid tissue,粘膜相关淋巴样组织÷
; Z% }3 y! Y3 d GMatching:配型5 J6 T( B' Z. v f( W
MBDI:marrow blast decline index骨髓原始细胞减少指数
- \- z/ E" ?" j# A# I1 RMC:mixed cellularity,混合细胞型
8 y' m* w2 y) L& ]! `) @McAb:monoclonal antibody,单克隆抗体2 R: v6 Y* j* g, u+ `
mCR: median complete remission,中位完全缓解 8 H3 k* } V3 x, C V
MDR:multiple drug resistance,多药耐药
) H2 D& W4 J4 A6 PMDS:myelodysplastic syndrome,骨髓增生异常综合征
G0 C; G% _5 cMegakaryocyte:巨核细胞
\8 y' e) }8 e8 U j4 J# q. VMetabolite:代谢物
8 }' }1 n* I# P! @. N1 R/ h: H* ~Metastatic:转移的
- R! A' g9 c8 v& j- ~% TMF:myelofibrosis,骨髓纤维化/ S% U: ]- \7 n4 W' E" |
MF:mycosis fungoides,蕈样霉菌病2 a; ^6 \* A; I3 k9 e" M
MGDS:megakaryocyte growth and differentiation factor,巨核细胞增殖分化因子) Y* f5 ]) j9 G$ X
MGP:marginal granulocyte pool,边缘粒细胞池
/ |- w( u; H% x; h; H: `' B1 T5 dMGUS: monoclonal gammopathy of undetermined significance,未定性的单克隆γ球蛋白血症
; L8 {% s( e5 t* |* i: B6 gMH:malignant histocytosis,恶性组织细胞增生症
( n( k5 g( O/ c vMHAS:minor histocompatibility antigen systems,次要组织相容性抗原系统
3 }! _7 }1 M* @/ J _" A# w" Z7 fMHC:major histocompatibility complex,主要组织相容性抗原复合体/ p8 W: L! v* \7 ?) k' U- _& s
MLC:mixed lymphocyte culture,混合淋巴细胞培养
$ x/ u- e0 s+ B3 ?& ^# S+ u! ZMLL:mixed lineage leukemia,混合系白血病7 M o6 n1 Z }, V: i) a* v
MM:multiple myeloma,多发性骨髓瘤& \% Q7 ^' C& p1 b {
MNC:mononuclear cells,单个核细胞" Y- ?1 h2 S/ n& q1 \" K# t
Mobilization:动员9 X4 W$ E0 X# ^: x
Monoclonal antibody:单克隆抗体 7 z5 N. i* J# m" |1 I& x! B& c
Monocyte:单核细胞 " W' ^# S+ o: k. ` m" g: d% z) d4 U2 Z
Monozygotic:单合子的: [' n3 u z. T- o+ M* M. F( c
Morbidity:发病率 9 k+ F: x- w7 Y9 K, Q/ e9 ~. q# W
MPD:myeloproliferative disease, 骨髓增殖性疾病
+ m4 k) t9 ? k8 XMPO:myeloperoxidase,髓过氧化物酶6 F# K0 }- R+ j0 l* U
MRD:minimal residual disease,微小残留病变 0 g$ J; R1 v9 K4 j- C- g: b
MRP:multidrug resistance-associated protein,多药耐药相关蛋白
9 z0 _8 j4 k# @( {Mucositis:粘膜炎
4 @$ v5 |1 R& A+ h f* F2 l" b' VMUD:matched unrelated donor,非血缘关系配型相合供体
- `4 j; S, H4 \, X5 ~2 BNAP:neutrophil alkaline phosphatase,中性粒细胞碱性磷酸酶7 Y$ A1 L: w3 E" r) l
NB:neuroblastoma,神经母细胞瘤
5 a L5 R3 s/ z3 r$ [- h& O2 {1 Q5 z. V5 @NBM:normal bone marrow,正常骨髓
1 D5 ]: h9 e2 }+ M0 tNegative selection:阴性选择0 ^- S7 W2 o1 t2 C1 `- V: ~
Neuro- :(前缀)神经的9 s/ J( D6 V: l6 p
Neutropenia:中性粒细胞减少症
8 U t0 [/ g" q9 F2 F/ m9 v" k+ CNeutrophil:中性粒细胞 - K3 ?8 M. B! I7 Z. [# u% g
NG:neutrophil granulocyte,中性粒细胞
7 z' C: M3 T6 U7 V8 Y0 G7 ENGF:nerve growth factor, 神经生长因子- l8 F! g2 B4 Y' M0 w$ {
NHL:non-Hodgkin's lymphoma,非霍奇金淋巴瘤: d7 F+ a% A* W( w
NK: nature killer cell,自然杀伤细胞
% }1 \; X+ U7 }. s' k( O0 H8 ANonmyeloablative transplantation: 非清髓性移植3 `6 G2 h, P9 I; e( R
NPO:不能进食 ! m6 }9 K1 I6 ~7 l' [
NS:nodular sclerosis,结节硬化型 8 L/ Q9 F/ l8 c8 G2 @
Oncology:肿瘤学 E6 D6 t- w$ ~9 }
Oto- :(前缀)耳的0 K( a# V- W4 g8 V8 O
PA:plasminogen activator,纤溶酶原激活物
5 V3 ^5 p3 n) c: y. KPacked red blood cells: 压积红细胞
, p$ m: w* }! \1 w H: ZPAE:post antibiotic effects,抗生素后续作用
. U% a0 z7 E [4 X" zPAI:plasminogen activator inhibitor,纤溶酶原激活物抑制剂
9 d# T% _/ y0 \Palliative:减轻的,缓解的 ! m) k; C0 y" p+ J% T
palliative care unit (PCU):终末期病房,临终关怀病房
6 m& Q+ M: c; T7 _1 ePancytopenia:全血细胞减少症
# E2 D2 T0 Q' A2 X* Y-pathy:(后缀)病 d2 D9 t+ Y+ V! M; G
PB:peripheral blood, 外周血
* n$ m j" \+ T; |) ^1 {. zPBL:peripheral blood lymphocyte,外周血淋巴细胞
/ N( @* J: F$ r5 K# f1 ]PBPC:peripheral blood progenitor cell,外周血祖细胞! \# s* G- P7 u" n, ^* V' M
PBSCT:peripheral blood stem cell transplantation,外周血干细胞移植2 \5 J, p0 l ~; X: e
PCA:procoagulant activity,促凝活性物质* k0 v. @& T- w) z
PCD:programmed cell death,细胞程序化死亡0 H J2 V3 E( |. h+ W
PCL:plasma cell leukemia,浆细胞白血病1 |- [/ T1 q( P6 L
PCLI:plasma cell label index,浆细胞标记指数
& o7 n* m( C# ^: C4 R- xPCR:polymerase chain reaction, 多聚酶链反应
. I/ `2 w6 L S1 M" dPCR-RFLP: PCR-restriction fragment length polymorphisms,限制性片段长度多态性分析
& c4 i# y# V; K) Y! k3 n2 ^PCR-SSOPH: PCR-sequence specific oligonucleotideprobe hybridization,序列特异性寡核苷酸探针杂交
& T/ w: n4 i9 YPDD:percentage depth dosage,百分深度剂量
- d* x; K& G" h' v+ ?PDGF:platelet derived growth factor,血小板衍生生长因子
: V" Q2 m/ s/ L2 r5 VPDR:primary drug resistance,原药耐药
, L, L8 n7 d; Q' C. \PE:plasma exchange,血浆置换. b0 ^' R# h6 D! G/ J2 u
-penia:(后缀)缺乏,不足 : N4 t1 d2 L. {. e1 S. _/ J- A
Peripheral neuropathy:周围神经病变 9 U& @: ~, v! L4 s
Petechiae:瘀点,瘀斑
/ E/ Y* J4 L Y4 yPfu: plaque forming unit,空斑形成单位- s- T# W) I* w( |7 j- [
PHA:phytahematoagglutinin,植物血凝素! f4 x# J" K& L. J. z4 v
Phlebitis:静脉炎
8 K5 M2 m% n0 }+ w' q7 ?7 lPHSC:pluripotential hematopoietic stem cell,多能造血干细胞
, K3 f, p) \# p6 d7 |-plasia:(后缀)发展,形成 / v( D5 g% t, l$ v0 I6 `1 P
Plasma:血浆. j4 R( _# h+ g' \6 j
Plasma cell: 浆细胞 1 g$ m5 O. E& D
Platelet:血小板 * ^0 u% m) b0 M# g( O8 f- w
PLG:plasminogen,纤溶酶原" P) \% L) e, N' V3 g ~
PLL:prolymphocytic leukemia,幼淋巴细胞白血病 g' Y% g' F+ q/ V5 k# L
PLT:platelet,血小板
* f! ~& |. R' Z+ dPLT:primed lymphocyte test,预致敏淋巴细胞试验7 n: b1 S4 t6 x! ^. S
PMN:polymorphonuclear leukocyte,多形核白细胞
. Z- u" U1 a& F( KPNH:paroxysmal nocturnal hemoglobinuria,阵发性睡眠性血红蛋白尿÷: P% b% L4 f% ]' ~7 M
PNRE:p53 negative response element,p53阴性反应元件* |5 h' S$ v! {# Y8 v2 d8 {+ C0 m
POD:PML oncogenic domain,PML癌基因结构域, B( d$ A9 `. ^# f" I
Polycythemia:红细胞增多症 8 w! C. [ r9 J. R
Positive selection:阳性选择2 ~- v- \, q: c5 {
PPSC: pluripotent hemotopoietic stem cell,全能造血干细胞
1 L) c7 |1 w4 f; aPreparative regimen:预处理方案
2 W- B+ B9 R4 l# \% i7 OProgenitor:前体,祖先5 B) D- v3 j3 u6 Y( w
Prognosis:预后
/ ^2 e, x3 A+ L1 p" mProphylactic:adj.预防的;n. 预防性,预防药
5 T- o" U/ b' ~0 \: YProphylaxis:预防法,预防% g- E* V7 R* `. F
Protocol:草案,协议,治疗方案 9 d+ ?" F1 B L
Proto-onc: proto-oncogene,原癌基因* u z4 C+ ]: W, m% I2 _4 m. d3 Z
PSS:posterior superior spine,髂后上棘
( p- Z6 a, S2 J* Z% c5 r4 tPT:prothrombin time,凝血酶原时间" D, E; }' r% u% O
PTCL:peripheral T celll lymphoma,外周T细胞型淋巴瘤
* x9 D6 J* ]* I/ A! s. \3 z: nPTH:post-transfusion hepatitis, 输血后肝炎
8 t/ r* _& b' e1 w6 X; ]6 PPulmonary:肺的
0 X" X8 J0 \5 u0 f, BPurging:净化
# i) x" f) O# W6 D& K3 IPurity:纯度; A9 j( P, y8 J/ Y* g
PV:polycythemia vera,真性红细胞增多症
1 i& l% m& n% ~& M) T- ]Quality of Life (QOL):生活质量" O, N$ n/ S& ~& z& f
RA:refractory anemia,难治性贫血
$ S( m( w& u' L _: D d! l# _% |RAEB:refractory anemia with excessive blasts,难治性贫血伴原始细胞增多型
* a; W& L. c m; U) @1 ~RAEB-T:refractory anemia with excessive blasts,transformation,难治性贫血伴原始细胞增多转化型: b+ K3 N3 t; y8 O! m& `; c
RAR:retinoic acid receptor,维甲酸受体
1 B9 F/ s9 v/ M9 _( h) V& R1 ]RAS:refractory anemia with sideroblasts,难治性贫血伴环状铁粒幼细胞增多) w7 L+ O9 _- z' d* m9 N, H* F) ?
RAS:retinoic acid syndrome,维甲酸综合征
3 m' p& Z' o) t' V; z& |; C% K7 q( YRB:retinoblastoma,视网膜母细胞瘤
3 `! G# q# Q8 L1 L4 q" U+ PRBC: red blood cell,红细胞 / s4 S* }8 \5 U9 g+ Q ^0 j. b
Reagent:试剂' W, j- Y g [! g1 L5 C
Recipient:受者 & I, Z& \5 v! E4 |
Rejection:排斥' X5 l, {. b" k/ L+ ~2 T2 Y& g
Relapse:复发
- r1 }) M1 t( N1 }Remission:缓解 ! H( ~7 @8 [9 S5 N( q, P
Renal:肾脏的,肾的 2 D) r& \- [- Q( g" K* ^* O# c
RFS:replase free survival,无复发生存
. r' E0 T+ e8 i" ~- xRPC:radiation protective competence, 辐射保护能力% q5 K# x9 p4 n" M% g
Regimen-related toxicity (RRT):预处理相关毒性
5 ]) I# D+ r/ b/ d! @RT-PCR:reverse transcription polymerase chain reaction, 逆转录多聚酶链反应
/ P/ U T9 t+ Q1 ~. q! rSBB:sudan black B,苏丹黑B
+ c4 W5 a/ ?# }9 X: lSCE:sister chromatial exchange,姐妹染色单体交换# H5 D' G/ K8 ]9 `4 t# @
SCF:stem cell factor,干细胞因子' b/ C( O. ~5 n0 l3 y. s
SCid:severe combined immunodeficiency disease,重症联合免疫缺陷5 {6 ~; U8 _' U* S2 w+ B* h4 C
SCL:stem cell leukemia,干细胞白血病, v4 j1 ], M$ f5 N% X( u2 `
SE:specific estarase,特异性酯酶
; A3 U2 n3 S! J/ g" V4 a( Y# Z1 r0 ZSelectin:选择素; G# A, Q, _6 c; q
Sense primer:同义引物
+ P) R% y& J# h1 QSeparation:(细胞)分选
& O# z6 n, u/ V& x4 tSepsis:脓血病,败血病
# X; n) v( O% d9 c7 b6 {. j# _Sequencing测序
( F& y( v: H* _5 f5 s3 qSF:serum ferritin,血清铁蛋白% S2 l& w3 t5 {
SHML:sinus histocytosis with massive lymphadenopathy,窦性组织细胞增生症伴块状淋巴结肿大5 ?8 Y7 c9 e h$ ]* h
SIA:stroma-support immunocytometric assay,基质支持免疫细胞流式细胞仪技术法
) H+ x5 H: T# M5 \SLE:systemic lupus erythematosus,系统性红斑狼疮! `4 E* T8 D5 ^9 _: a
SLL:small lymphocytic lymphoma,小淋巴细胞淋巴瘤6 H0 N4 t6 {/ q7 L( @
Solid tumor:实体瘤
3 r0 W7 C3 ?" a8 d Q+ [) KSR-ALL:standard risk acute lymphocytic leukemia,标危型急性淋巴细胞白血病$ ~: ?$ e+ d) l3 f- s3 N' w
SRC:SCid/NOD小鼠体内增殖的人造血干细胞,SCid造血重建细胞
6 O1 `6 `2 n9 K1 O9 y8 e& ^SS:Sezary syndrome,Sezary综合征
3 y1 j2 }' x/ {Stem cell:干细胞6 _. L L0 y h! ]3 p! F
STNI:subtotal nodal irradiation,次全淋巴结照射
$ r; k2 Q# o0 H7 XStomatitis:口炎 4 A& S r' l6 v& c
Subclavian catheter:锁骨下导管 1 A# n3 _. F( q# }8 \/ u
Supernatant:上清
, V V8 @9 m5 y" CSyn-BMT:Syngeneic bone marrow transplant:同基因骨髓移植 ( E1 W) @5 o$ x0 u3 U
Syngeneic:同基因的, |1 \- b9 @& T1 R
TAM:tumor associated macrophage,肿瘤相关巨噬细胞
& I h, o% I+ \' e" yt-AML:treatment associated AML,治疗相关的急性髓性白血病# ]5 E# K( L0 D3 u$ u
TA-GVHD:transfusion associated graft-versus-host disease,输血相关的移植物抗宿主病
4 ~) j. V$ i( r4 i2 CTAA:tumor associated antigen,肿瘤相关抗原
, z1 P h7 j0 L: \, G2 JTBGP:total blood granulocyte pool,总血液粒细胞池
% o% v( G5 o+ Q( }8 _2 W( @TBI:total body irradiation,全身照射1 j& m& P* [6 F; i) y
Tc:time of cell cycle, 细胞周期时间- s" w* q8 [" n& k
TCD:T cell depletion, T细胞去除
" p) j8 X1 l$ ~/ F6 n# M/ a2 oTCL:T cell leukemia/lymphoma,T细胞白血病/淋巴瘤 1 ?+ d# b; J0 \+ a6 o
TCR:T cell receptor,T细胞受体
; O9 K5 E% }2 h; fTCS:tumor cell survival,肿瘤细胞成活
; D% ~$ G1 Z7 z: {, l7 ^" sTEN:total enteral nutrition,完全胃肠内营养
% b3 n) c& n# d& u% t' h2 h# }, STF:tissue factor,组织因子
I% s- b8 `; _TF:thymic factor,胸腺因子2 q& ?- b1 w- X Q, H2 ?. x
TFPI:tissue factor pathway inhibitor,组织因子途径抑制物1 w% C3 r$ X0 r# Z# M8 T- A* U- P
TGF:therapeutic gain factor,治疗获得系数. Q7 ]5 G4 ^ {! G. E
TGF-β:transforming growth factor-β,转化生长因子β6 X; K% I" B" G+ D( A0 w* d- g
Thrombocyte:血小板 5 j5 H. l( w- ?, X; ^
Thrombocytopenia:血小板减少症
# f/ \) U+ Z; g7 h9 y1 JTIL:tumor infiltrate lymphocyte,肿瘤浸润淋巴细胞
9 }. O* f d2 p- ~& ETL:testis leukemia睾丸白血病
1 M: V; W& Q( H" x [( B; ~. FTLI:total Lymphoid irradiation,全淋巴照射
+ R: B/ d" S( F/ A+ gThrombotic microangiopathy (TMA):血栓性微血管病
9 f+ F$ D9 p* x3 b7 f& DTNF:tumor necrosis factor,肿瘤坏死因子% B9 a$ l7 h& D
TNI:total nodal irradiation,全淋巴结照射
5 E8 J0 _8 J1 x% s( _0 D! ZTOPO II:topoisomerase II,拓扑易构酶II. y3 E0 _8 Z6 c* l4 k+ d: S& N
Toxin:毒素 4 p4 o* p3 I, f5 X$ u B: H
Tpdt:potential doubling time,倍增时间' \ L1 K9 [/ t/ H# l
T-PLL:T-prolymphocytic leukemia,T幼淋细胞白血病
! ?) B, s! ^% l+ J( DTPN:total parenteral nutrition,全肠道外营养,静脉高营养
4 h6 f+ l" @- b6 W- i& L1 RTPO:thrombopoietin,促血小板生成素
3 K7 D% [% H# Z1 c8 ?1 vTPS:treatment planning system,治疗计划系统
6 A1 U" M+ H: p) f0 STranslocation:易位. h# u" `$ |) z2 d
Trauma:创伤 $ ]( a, E4 v) i& { ?3 u) j
TRM:transplantation related mortality,移植相关死亡率
1 V" d" y9 s6 XTSC:timed-sequential chemotherapy,时相序贯化疗
6 t; h! D c: _* r$ } h6 D8 T: TTSPA:triophosphoramide,噻替派
( Q7 f' P+ s `TTP:thrombotic thrombocytopenic purpura,血栓性血小板减少性紫癜% i6 n4 O% f. I
Tumor:肿瘤 ; [5 [, U! E, {! K3 F0 c# J) w! e/ V
Tumor burden:肿瘤负荷
9 \( c7 f2 S' o) t; Q2 }UCB:umbilical cord blood,脐带血
8 s6 J8 [" n! J; u5 K% cUltrasound:超声 ( R# h1 G( }8 G& ~: s0 C
Umbilical cord:脐带8 m, I/ G8 K2 Y: [. M7 n7 @
VAHS:viral associated hemophagocytic syndrome,病毒相关嗜血细胞综合征$ \; `, w, N% u" ^7 v
VGPR:very good partial remission,非常良好的部分缓解3 o# ?* d( H3 A$ m
Viability:活性
. N, q: q& a9 C& |7 B- Z5 x5 S1 T1 EVirus:病毒
* x2 ~* f) A- F) rVOD:veno-occlusive disease,静脉阻塞性疾病 $ a; N. v, {3 m
v-onc: virus oncogene,病毒癌基因
T' T, e5 N- o# X, `& {, zVPF: vascular permeability factor,血管渗透因子
% q3 E& N' F8 z6 vVZV:varicella zoster virus,水痘带状疱疹病毒
( W9 R# r) t$ [$ g, f2 q+ HWBC:white blood cell,白细胞 ; o: ^# C8 H" q( Q
Whole blood:全血 3 Y1 v, r% D! Z" ~+ N6 d
WT:Wilms tumor,肾母细胞瘤0 @. p/ m. K2 c) ?0 R# K+ ? s! r
Xerostomia:口腔干燥症
) n1 Q0 R* F$ ?3 j- YYield:产量 |
|